BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,779,174 | +2.1% | 1,001,038 | +23.2% | 0.01% | 0.0% |
| Q2 2023 | $37,016,999 | -35.8% | 812,489 | -42.8% | 0.01% | -38.1% |
| Q1 2023 | $57,660,542 | -20.0% | 1,421,611 | +0.6% | 0.02% | -22.2% |
| Q4 2022 | $72,032,333 | +40.6% | 1,413,230 | +48.5% | 0.03% | +22.7% |
| Q3 2022 | $51,240,000 | +26.5% | 951,363 | +50.8% | 0.02% | +29.4% |
| Q2 2022 | $40,516,000 | -14.7% | 630,794 | +3.0% | 0.02% | +6.2% |
| Q1 2022 | $47,501,000 | -24.8% | 612,604 | -16.7% | 0.02% | -11.1% |
| Q4 2021 | $63,163,000 | +4.0% | 735,813 | -2.6% | 0.02% | -5.3% |
| Q3 2021 | $60,751,000 | +3.1% | 755,333 | +3.2% | 0.02% | 0.0% |
| Q2 2021 | $58,944,000 | -12.6% | 732,211 | -8.4% | 0.02% | -17.4% |
| Q1 2021 | $67,446,000 | -9.2% | 799,688 | -13.6% | 0.02% | -8.0% |
| Q4 2020 | $74,287,000 | -0.3% | 925,804 | -0.0% | 0.02% | -10.7% |
| Q3 2020 | $74,491,000 | -37.0% | 926,264 | -32.6% | 0.03% | -44.0% |
| Q2 2020 | $118,315,000 | +117.6% | 1,374,170 | +105.2% | 0.05% | +92.3% |
| Q1 2020 | $54,374,000 | -38.6% | 669,711 | -36.8% | 0.03% | -13.3% |
| Q4 2019 | $88,544,000 | -12.2% | 1,058,897 | -8.2% | 0.03% | -23.1% |
| Q3 2019 | $100,887,000 | +17.2% | 1,153,390 | +9.7% | 0.04% | +18.2% |
| Q2 2019 | $86,089,000 | +35.1% | 1,051,151 | +34.1% | 0.03% | +26.9% |
| Q1 2019 | $63,737,000 | +50.7% | 783,876 | +22.0% | 0.03% | +36.8% |
| Q4 2018 | $42,287,000 | -30.2% | 642,452 | -18.2% | 0.02% | -20.8% |
| Q3 2018 | $60,579,000 | +2.7% | 785,816 | -1.6% | 0.02% | -7.7% |
| Q2 2018 | $58,998,000 | -0.2% | 798,999 | -12.1% | 0.03% | 0.0% |
| Q1 2018 | $59,139,000 | +15.9% | 909,264 | +15.2% | 0.03% | +23.8% |
| Q4 2017 | $51,027,000 | +21.6% | 789,400 | +18.0% | 0.02% | +10.5% |
| Q3 2017 | $41,978,000 | +2.7% | 668,978 | -0.9% | 0.02% | -9.5% |
| Q2 2017 | $40,886,000 | -22.2% | 675,360 | -33.4% | 0.02% | -27.6% |
| Q1 2017 | $52,573,000 | +76.6% | 1,013,726 | +51.0% | 0.03% | +81.2% |
| Q4 2016 | $29,775,000 | -41.1% | 671,517 | -36.8% | 0.02% | -46.7% |
| Q3 2016 | $50,579,000 | -0.1% | 1,062,590 | -5.0% | 0.03% | -6.2% |
| Q2 2016 | $50,605,000 | +71.3% | 1,119,080 | +55.6% | 0.03% | +60.0% |
| Q1 2016 | $29,539,000 | +9.3% | 719,045 | +1.5% | 0.02% | +11.1% |
| Q4 2015 | $27,025,000 | +81.4% | 708,402 | +56.2% | 0.02% | +63.6% |
| Q3 2015 | $14,898,000 | -95.0% | 453,525 | -89.4% | 0.01% | -94.4% |
| Q2 2015 | $298,056,000 | +200.2% | 4,262,191 | +194.1% | 0.20% | +187.0% |
| Q1 2015 | $99,277,000 | -22.9% | 1,449,277 | -17.5% | 0.07% | -23.3% |
| Q4 2014 | $128,825,000 | – | 1,757,744 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |